Balance Sheet HealthLow leverage and a strong equity base provide durable financial flexibility: supports investment in product development, working capital for distribution, and resilience through industry cycles. This stability reduces refinancing risk and preserves strategic optionality over months.

Diversified Revenue StreamsA multi-segment business model (branded formulations, consumer products, devices and contract manufacturing) lowers revenue concentration risk and smooths demand volatility. Institutional channels and retail distribution create multiple durable demand sources and cross-selling opportunities.

Revenue Growth & Gross MarginSustained revenue expansion paired with healthy gross margins indicates effective pricing and cost control within core products. This combination supports reinvestment in brands and distribution, underpinning medium-term earnings potential and competitive positioning.

Bears Say

Cash Flow WeaknessPersistent negative operating and free cash flow can constrain capital allocation, limit funding for marketing or device inventory, and force reliance on external financing despite low leverage. Over months, weak cash conversion hampers sustainable growth and dividend capacity.

Margin CompressionA falling EBITDA margin points to rising SG&A or production costs or pricing pressure. If structural, margin erosion reduces profitability, limits reinvestment and leaves the company more exposed to cost inflation and competitive pricing over the medium term.

Earnings VolatilityA sharp decline in EPS signals profit variability that can reflect margin pressure, one-offs, or lower operational leverage. Reduced earnings growth weakens retained earnings and strategic financing capacity, making execution of long-term initiatives more challenging.

TTK Healthcare Limited News

TTK Healthcare Seeks Shareholder Nod via E-Voting to Appoint New Independent Director

TTK Healthcare Limited ( ($IN:TTKHLTCARE) ) has issued an announcement. TTK Healthcare Limited has launched a postal ballot...

2M ago

TTK Healthcare Board Appoints New Independent Director, Seeks Shareholder Nod via Postal Ballot

An update from TTK Healthcare Limited ( ($IN:TTKHLTCARE) ) is now available. TTK Healthcare Limited’s board has approved...

2M ago

TTKHLTCARE FAQ

What was TTK Healthcare Limited’s price range in the past 12 months?

TTK Healthcare Limited lowest stock price was ₹906.30 and its highest was ₹1402.00 in the past 12 months.

What is TTK Healthcare Limited’s market cap?

TTK Healthcare Limited’s market cap is ₹12.91B.

When is TTK Healthcare Limited’s upcoming earnings report date?

TTK Healthcare Limited’s upcoming earnings report date is May 22, 2026 which is in 82 days.

How were TTK Healthcare Limited’s earnings last quarter?

TTK Healthcare Limited released its earnings results on Jan 22, 2026. The company reported ₹7.454 earnings per share for the quarter, beating the consensus estimate of N/A by ₹7.454.

Is TTK Healthcare Limited overvalued?

According to Wall Street analysts TTK Healthcare Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does TTK Healthcare Limited pay dividends?

TTK Healthcare Limited pays a Annually dividend of ₹10 which represents an annual dividend yield of 0.95%. See more information on TTK Healthcare Limited dividends here

What is TTK Healthcare Limited’s EPS estimate?

TTK Healthcare Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does TTK Healthcare Limited have?

TTK Healthcare Limited has 14,130,333 shares outstanding.

What happened to TTK Healthcare Limited’s price movement after its last earnings report?

TTK Healthcare Limited reported an EPS of ₹7.454 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.839%.

Which hedge fund is a major shareholder of TTK Healthcare Limited?

Currently, no hedge funds are holding shares in IN:TTKHLTCARE

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

TTK Healthcare Limited

TTK Healthcare Limited engages in the animal welfare and human pharma product, consumer product, medical device, protective device, and food businesses in India and internationally. Its Animal Welfare segment deals in various therapeutic formulations and feed supplements for veterinary use. The company's Consumer Products segment is involved in the marketing and distribution of Woodward's Gripewater, EVA range of cosmetics, Good Home range of scrubbers, air fresheners, etc. its Medical Devices segment manufactures and distributes artificial heart valves; and develops orthopedic implants and instruments. The company's Protective Devices segment manufactures and markets male contraceptives and other allied products. Its Foods segment engages in the manufacturing and marketing of food products, including potato and cereal based pellets. The company's Others segment prints and publishes maps and atlases. Its Human Pharma segment deals in herbal and allopathic formulations for human use. The company was incorporated in 1958 and is headquartered in Chennai, India. TTK Healthcare Limited is a subsidiary of TT Krishnamachari & Co., Ltd.